5 September, 2014 by The TZ Newswire Staff Comments Off on Starbucks to expand premium coffee stores, open tasting room
Starbucks to expand premium coffee stores, open tasting room
Move comes as coffee chain faces increased competition from upscale coffee makers.
read more
5 September, 2014 by The TZ Newswire Staff Comments Off on Live: Jobs report; Gap tanks; Microsoft unveils ‘selfie cam’
Live: Jobs report; Gap tanks; Microsoft unveils ‘selfie cam’
Join us live now for the latest on the August jobs report, stocks on the move and a Fed report that show the income gap is widening.
5 September, 2014 by The TZ Newswire Staff Comments Off on Apple says it will add new security measures after celebrity hack
Apple says it will add new security measures after celebrity hack
The company said it would add alerts to tell people about activities that could be signs of a break-in.
5 September, 2014 by The TZ Newswire Staff Comments Off on Fed says growth lifts the affluent, leaving behind everyone else
Fed says growth lifts the affluent, leaving behind everyone else
Economic growth since the Great Recession has improved the fortunes of the most affluent Americans as the income of most American families continues to decline.
5 September, 2014 by The TZ Newswire Staff Comments Off on Economic Report: Hiring slows as U.S. adds 142,000 jobs in August
Economic Report: Hiring slows as U.S. adds 142,000 jobs in August
Hiring in the United States slowed in August as the economy created just 142,000 jobs, marking the smallest gain since December. That ended a six-month streak in which the U.S.
5 September, 2014 by The TZ Newswire Staff Comments Off on Airlines least likely to require a ‘Knee Defender’
Airlines least likely to require a ‘Knee Defender’
Economy seats aren’t created equal. How to get the most legroom for the least amount of money.
5 September, 2014 by The TZ Newswire Staff Comments Off on Is It Time to Buy Shares in This Marijuana Stock?
Is It Time to Buy Shares in This Marijuana Stock?
GW Pharmaceuticals Plc has an intriguing slate of marijuana-based medicine under development, but that may not mean that shares will continue to climb.